Upgrade to SI Premium - Free Trial

BioNTech (BNTX) PT Raised to $126 at BMO Capital

November 4, 2024 4:06 PM
BMO Capital analyst Etzer Darout raised the price target on BioNTech (NASDAQ: BNTX) to $126.00 (from $122.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles